GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Lifeline Scientific Inc (LSE:LSI) » Definitions » Forward PE Ratio

Lifeline Scientific (LSE:LSI) Forward PE Ratio : 0.00 (As of Jun. 05, 2024)


View and export this data going back to . Start your Free Trial

What is Lifeline Scientific Forward PE Ratio?

Lifeline Scientific's Forward PE Ratio for today is 0.00.

Lifeline Scientific's PE Ratio without NRI for today is 6.57.

Lifeline Scientific's PE Ratio for today is 6.57.


Lifeline Scientific Forward PE Ratio Historical Data

The historical data trend for Lifeline Scientific's Forward PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lifeline Scientific Forward PE Ratio Chart

Lifeline Scientific Annual Data
Trend
Forward PE Ratio

Lifeline Scientific Semi-Annual Data
Forward PE Ratio

Competitive Comparison of Lifeline Scientific's Forward PE Ratio

For the Medical Devices subindustry, Lifeline Scientific's Forward PE Ratio, along with its competitors' market caps and Forward PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lifeline Scientific's Forward PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Lifeline Scientific's Forward PE Ratio distribution charts can be found below:

* The bar in red indicates where Lifeline Scientific's Forward PE Ratio falls into.



Lifeline Scientific Forward PE Ratio Calculation

It's a measure of the price-to-earnings ratio (PE Ratio) using forecasted earnings for the calculation. While the earnings used are just an estimate and are not as reliable as current earnings data, there is still benefit in estimated P/E analysis. The forecasted earnings used in the formula can either be for the next 12 months or for the next full-year fiscal period.


Lifeline Scientific  (LSE:LSI) Forward PE Ratio Explanation

The Forward PE Ratio of a company is often used to compare current earnings to estimated future earnings, as well as gaining a clearer picture of what earnings will look like without charges and other accounting adjustments. If earnings are expected to grow in the future, the Forward PE Ratio will be lower than the current PE Ratio. This measure is also used to compare one company to another with a forward-looking focus.

Trailing PE Ratio relies on what is already done. It uses the current share price and divides by the total EPS (Basic) over the past 12 months. PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio .


Lifeline Scientific Forward PE Ratio Related Terms

Thank you for viewing the detailed overview of Lifeline Scientific's Forward PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Lifeline Scientific (LSE:LSI) Business Description

Traded in Other Exchanges
N/A
Address
Lifeline Scientific Inc was incorporated on October 1, 1998. The Company is in the business of delivering, to targeted medical markets, a portfolio of related proprietary technologies, which include devices, solutions, and protocols designed to maximize the use and availability of organs, tissues, and cells. It serves the kidney transplant market today with its LifePort product line, and also sells solutions to service the broader organ transplant industry. The Company operates in North America, Brazil, China and Rest of World.

Lifeline Scientific (LSE:LSI) Headlines